Jefferies Group's IMNM Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 2 M shares of Immunome, Inc. (IMNM) worth $42.96 M, representing 0.22% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Jefferies Group has maintained this position in IMNM for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2024, adding 1.88 M shares. Largest reduction occurred in Q2 2025, reducing 202,340 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Immunome (IMNM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunome (IMNM) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -100,000 | Reduce 4.76% | 2 M | $21.48 |
| Q3 2025 | +14,340 | Add 0.69% | 2.1 M | $11.71 |
| Q2 2025 | -202,340 | Reduce 8.84% | 2.09 M | $9.30 |
| Q1 2025 | +288,000 | Add 14.40% | 2.29 M | $6.73 |
| Q4 2024 | +124,108 | Add 6.62% | 2 M | $10.62 |
| Q3 2024 | +1.88 M | New Buy | 1.88 M | $14.62 |
| Q2 2024 | -8,740 | Sold Out | 0 | $0.00 |
| Q1 2024 | +8,740 | New Buy | 8,740 | $24.68 |
Jefferies Group's Immunome Investment FAQs
Jefferies Group first purchased Immunome, Inc. (IMNM) in Q1 2024, acquiring 8,740 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Immunome, Inc. (IMNM) for 8 quarters since Q1 2024.
Jefferies Group's largest addition to Immunome, Inc. (IMNM) was in Q3 2024, adding 1,875,892 shares worth $27.43 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 2,000,000 shares of Immunome, Inc. (IMNM), valued at approximately $42.96 M.
As of the Q4 2025 filing, Immunome, Inc. (IMNM) represents approximately 0.22% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Immunome, Inc. (IMNM) was 2,288,000 shares, as reported at the end of Q1 2025.